A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Market Scope
Trusted Global Partner of Industry and Medical Professionals for Ophthalmic Market Research, Primary Research, Independent Perspective, & Objective Analysis
Choose Your Experience
Over 500 Clients, Large & Small from Around the World, Trust Market Scope Data & Analysis
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 409
Comprehensive Pages
- 40
Competitors Profiled
- 11
IOL Categories Forecasted
- 8
Geographic and Economic Breakouts
2026 IOL Market Report: Global Analysis for 2025 to 2031, March, 2026
The “2026 IOL Market Report” delivers a comprehensive, data-driven view of the global intraocular lens market, combining detailed analysis of today’s landscape with five-year forecasts designed to inform strategy, investment, and competitive positioning.
Built on Market Scope’s proprietary models and deep industry insight, the report identifies the trends shaping demand, tracks shifts in technology adoption, and highlights the factors that will define success in an increasingly competitive and innovation-driven market.
The analysis segments the market across 11 distinct IOL categories—commodity monofocal, enhanced monofocal/intermediate-optimized monofocal, toric, PC-toric, bifocal, trifocal, extended depth of focus (EDOF), EDOF multifocal hybrid, accommodating, postoperatively adjustable, and phakic IOLs— to provide a clear view of where growth is occurring and how the premium market continues to evolve.
In addition, the report profiles 40 leading companies, offering insight into their product portfolios, strategic positioning, competitive strengths, and future outlook to provide you with the intelligence needed to benchmark competitors and identify opportunities in the global IOL market.
Latest Industry News & Trends
4/3/2026
BreakingDealsPharmaRetina
Biogen to Acquire Apellis for $5.6 Billion with Eye Toward Growth
Biogen reported March 31 that it had agreed to acquire Apellis Pharmaceuticals, maker of Syfovre, for about $5.6 billion in cash to expand its portfolio of rare-disease medicines. Under the deal, ...
4/3/2026
BreakingPharmaPresbyopia
Tenpoint Launches Yuvezzi Drops for Presbyopia in US
Tenpoint Therapeutics announced March 30 that it had launched Yuvezzi (carbachol and brimonidine tartrate ophthalmic solution 2.75%/0.1%) for presbyopia in the US. Tenpoint, with offices in London,...
4/3/2026
BreakingLaserOptometryRegulationScope of Practice
New Hampshire Governor Vetoes Bill to Allow ODs to Perform SLT, LPI, YAG Capsulotomy
New Hampshire Gov. Kelly Ayotte on March 27 vetoed House Bill 349, which would have expanded the scope of practice for optometrists in the state, allowing them to perform selective laser trabeculop...
4/3/2026
BreakingCataractFLACSRevenueSurgical
Lensar Reports 2025 Revenue of $58.4 Million
Lensar, of Orlando, Florida, reported March 31 that its 2025 revenue was $58.4 million, a 9 percent increase over $53.5 million in 2024. Lensar noted that 79 percent of its 2025 revenue came from r...
4/3/2026
BreakingChinaFundingStudy
China Gaining on US for Leadership in Early-Stage Drug Development, Georgetown Researchers Report
Early-stage drug development has increased dramatically over the past decade, with China gaining the most ground and challenging the US for leadership, according to Georgetown University. Georgetow...
4/3/2026
BreakingCataractIOLSurgical
VirtuaLens IOL Simulator Now Includes Monovision Feature
VirtuaLens, of Austin, Texas, reported March 23 that its intraocular lens (IOL) simulator now offers a monovision feature. The wireless VR headset is designed to help patients understand their opti...
4/3/2026
BreakingCataractPharmaRegulation
Health Canada Approves Clobetasol Propionate Eye Drops for Postsurgical Pain, Inflammation
Canada’s Apotex announced March 25 that regulators there had approved Clobivis (clobetasol propionate ophthalmic suspension, 0.05%) for the treatment of postoperative inflammation and pain followin...
4/3/2026
BreakingCataractClinical TrialIOLRegulationSurgical
US FDA Gives Green Light to Trial of Long Bridge’s Prosthetic Capsular Bag
Long Bridge Medical announced March 26 that the US FDA had signed off on its investigational device exemption (IDE) submission, allowing the company to proceed with a pivotal trial of LensOne, its ...
Provider Surveys & Interviews
Grab a seat at the table and join the thousands of ophthalmologists and optometrists from over 60 countries who are helping shape the next generation of diagnostics, pharmaceuticals, devices, and equipment by sharing your opinion and experience. Make your voice heard!
Choose Your Own Adventure
Participation options include weekly polls, special sponsored surveys, syndicated quarterly surveys, focus groups, and interviews, each with varying levels of honoraria.
Safe, Secure & On Any Device
We follow all industry standards to ensure confidentiality between participants and clients. Start and stop surveys anytime on our free Market Scope+ App or on desktop, each with a personalized dashboard just for you.
Pre-Qualified Invitations
We individually verify all potential participants before each survey or interview, ensuring that only licensed eye care professionals are invited and they are never kicked out or disqualified.
Better Data = Better Decisions
A team of industry experts and analysts review each data point, so you can be confident in the results and trends provided in our reports.
Download the Market Scope+ app to get started!
Market Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.